Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PD173074 | 219580-11-7 | sc-202610 sc-202610A sc-202610B | 1 mg 5 mg 50 mg | $47.00 $143.00 $680.00 | 16 | |
This is a small-molecule compound that has been investigated for its potential to inhibit FGF receptor tyrosine kinase activity, which could indirectly impact FGF-20 signaling. | ||||||
BGJ398 | 872511-34-7 | sc-364430 sc-364430A sc-364430B sc-364430C | 5 mg 10 mg 50 mg 100 mg | $216.00 $252.00 $594.00 $1009.00 | 4 | |
Another selective FGFR inhibitor, potentially inhibiting FGF-20 mediated signaling. | ||||||
SU 5402 | 215543-92-3 | sc-204308 sc-204308A | 1 mg 5 mg | $63.00 $98.00 | 36 | |
Another small-molecule inhibitor, SU5402, has shown inhibitory effects on FGF receptor signaling and could potentially affect FGF-20-mediated pathways. | ||||||
AZD4547 | 1035270-39-3 | sc-364421 sc-364421A | 5 mg 10 mg | $198.00 $309.00 | 6 | |
A FGFR inhibitor, may block FGF-20 action by inhibiting its receptors. | ||||||
Dovitinib, Free Base | 405169-16-6 | sc-396771 sc-396771A | 10 mg 25 mg | $170.00 $350.00 | ||
A multi-targeted tyrosine kinase inhibitor, can inhibit FGFRs among others, possibly affecting FGF-20 signaling. | ||||||
BIBF1120 | 656247-17-5 | sc-364433 sc-364433A | 5 mg 10 mg | $184.00 $321.00 | 2 | |
A tyrosine kinase inhibitor, targets FGFR, PDGFR, and VEGFR, potentially impacting FGF-20 pathways. | ||||||
Erdafitinib | 1346242-81-6 | sc-507388 | 10 mg | $138.00 | ||
A pan-FGFR inhibitor, could inhibit signaling pathways mediated by FGF-20. | ||||||
AP 24534 | 943319-70-8 | sc-362710 sc-362710A | 10 mg 50 mg | $175.00 $983.00 | 2 | |
A multi-kinase inhibitor, potentially inhibits FGFRs and influences FGF-20 signaling. | ||||||
Lenvatinib | 417716-92-8 | sc-488530 sc-488530A sc-488530B | 5 mg 25 mg 100 mg | $182.00 $661.00 $1690.00 | 3 | |
A multi-target inhibitor of VEGFR, FGFR, PDGFR, RET and KIT, can affect FGF-20 mediated pathways. | ||||||
Pazopanib | 444731-52-6 | sc-396318 sc-396318A | 25 mg 50 mg | $130.00 $182.00 | 2 | |
A multi-kinase inhibitor targeting VEGFR, PDGFR, and FGFR, could indirectly affect FGF-20 signaling. | ||||||